Follow
Dhruv Kumar
Title
Cited by
Cited by
Year
Oxidative stress in cancer cell metabolism
S Arfin, NK Jha, SK Jha, KK Kesari, J Ruokolainen, S Roychoudhury, ...
Antioxidants 10 (5), 642, 2021
3402021
Specific targeting cancer cells with nanoparticles and drug delivery in cancer therapy
S Raj, S Khurana, R Choudhari, KK Kesari, MA Kamal, N Garg, ...
Seminars in cancer biology 69, 166-177, 2021
2732021
Rottlerin induces autophagy and apoptosis in prostate cancer stem cells via PI3K/Akt/mTOR signaling pathway
D Kumar, S Shankar, RK Srivastava
Cancer letters 343 (2), 179-189, 2014
2342014
Rottlerin induces autophagy which leads to apoptotic cell death through inhibition of PI3K/Akt/mTOR pathway in human pancreatic cancer stem cells
BN Singh, D Kumar, S Shankar, RK Srivastava
Biochemical pharmacology 84 (9), 1154-1163, 2012
2312012
Biomolecular characterization of exosomes released from cancer stem cells: possible implications for biomarker and treatment of cancer
D Kumar, D Gupta, S Shankar, RK Srivastava
Oncotarget 6 (5), 3280, 2015
1722015
Epigenetic modifications by dietary phytochemicals: implications for personalized nutrition
S Shankar, D Kumar, RK Srivastava
Pharmacology & therapeutics 138 (1), 1-17, 2013
1592013
Evidence of Coronavirus (CoV) Pathogenesis and Emerging Pathogen SARS-CoV-2 in the Nervous System: A Review on Neurological Impairments and Manifestations
DK Jha NK, Ojha S, Jha SK, Dureja H, Singh SK, Shukla SD, Chellappan DK ...
Journal of Molecular Neuroscience, www.doi/10.1007/s12031-020-01767-6, 2021
156*2021
Rottlerin-induced autophagy leads to the apoptosis in breast cancer stem cells: molecular mechanisms
D Kumar, S Shankar, RK Srivastava
Molecular cancer 12 (1), 1-15, 2013
1432013
Arsenic exposure in Indo Gangetic plains of Bihar causing increased cancer risk
A Kumar, M Ali, R Kumar, M Kumar, P Sagar, RK Pandey, V Akhouri, ...
Scientific Reports 11 (1), 2376, 2021
1352021
NVP-LDE-225 (Erismodegib) inhibits epithelial–mesenchymal transition and human prostate cancer stem cell growth in NOD/SCID IL2Rγ null mice by regulating Bmi-1 and microRNA-128
R Nanta, D Kumar, D Meeker, M Rodova, PJV Veldhuizen, ...
Oncogenesis 2 (42), 2013
1252013
Discovery of New Hydroxyethylamine Analogs against 3CLpro Protein Target of SARS-CoV-2: Molecular Docking, Molecular Dynamics Simulation, and Structure …
S Kumar, PP Sharma, U Shankar, D Kumar, SK Joshi, L Pena, ...
Journal of chemical information and modeling 60 (12), 5754-5770, 2020
1232020
Cancer-associated fibroblasts drive glycolysis in a targetable signaling loop implicated in head and neck squamous cell carcinoma progression
D Kumar, J New, V Vishwakarma, R Joshi, J Enders, F Lin, S Dasari, ...
Cancer research 78 (14), 3769-3782, 2018
1182018
In silico identification of potent FDA approved drugs against Coronavirus COVID-19 main protease: A drug repurposing approach
D Kumar, V Chandel, S Raj, B Rathi
Chemical Biology Letters 7 (3), 166-175, 2020
982020
Andrographolide inhibits osteopontin expression and breast tumor growth through down regulation of PI3 kinase/Akt signaling pathway
S Kumar, H S Patil, P Sharma, D Kumar, S Dasari, V G Puranik, ...
Current Molecular Medicine 12 (8), 952-966, 2012
852012
Antioxidants in Alzheimer's Disease: Current Therapeutic Significance and Future Prospects
JSK Pritam P, Deka R, Bhardwaj A, Srivastava R, Kumar D, Jha AK, Jha NK, Villa C
Biology (Basel) 11 (2), 212, 2022
732022
The chaperone-like protein 14-3-3η interacts with human α-synuclein aggregation intermediates rerouting the amyloidogenic pathway and reducing α-synuclein cellular toxicity
N Plotegher, D Kumar, I Tessari, M Brucale, F Munari, L Tosatto, ...
Human molecular genetics 23 (21), 5615-5629, 2014
722014
Molecular mechanism (s) of regulation (s) of c-MET/HGF signaling in head and neck cancer
S Raj, KK Kesari, A Kumar, B Rathi, A Sharma, PK Gupta, SK Jha, NK Jha, ...
Molecular Cancer 21 (1), 1-16, 2022
702022
In silico identification of potent COVID-19 main protease inhibitors from FDA approved antiviral compounds and active phytochemicals through molecular docking: A drug …
V Chandel, S Raj, B Rathi, D Kumar
MDPI AG, 2020
702020
Mitigation of tumor-associated fibroblast-facilitated head and neck cancer progression with anti–hepatocyte growth factor antibody ficlatuzumab
D Kumar, C Kandl, CDA Hamilton, Y Shnayder, TT Tsue, K Kakarala, ...
JAMA Otolaryngology–Head & Neck Surgery 141 (12), 1133-1139, 2015
552015
Structure-based drug repurposing for targeting Nsp9 replicase and spike proteins of severe acute respiratory syndrome coronavirus 2
V Chandel, PP Sharma, S Raj, R Choudhari, B Rathi, D Kumar
Journal of Biomolecular Structure and Dynamics 40 (1), 249-262, 2022
512022
The system can't perform the operation now. Try again later.
Articles 1–20